Axonics, Inc.

📍 Irvine, United States🗓 Founded 2013👥 563 employees💰 Last funded Mar 2019
Axonics® is dedicated to improving the quality of life of people suffering from bladder and bowel dysfunction, conditions that impact the lives of tens of millions of adults globally. The Company’s products include the Axonics Sacral Neuromodulation System designed to treat overactive bladder and fecal incontinence and the Bulkamid® hydrogel designed to treat women with stress urinary incontinence. For more information, visit www.axonics.com and www.bulkamid.com.   Axonics, Inc. (Nasdaq: AXNX) is headquartered in Irvine, California.
3
Total investors
0
Early stage
2
Mid stage
1
Late stage
2013
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Late stage· 1
?
Board Member
late stage
Mar 2019
Investor geography1 country
United States
1
Investor activity2018–2019 · investors recorded per year
2018220191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Axonics, Inc.?
Axonics, Inc. has 3 investors on record on gritt.io, 2 mid-stage and 1 late-stage investors.
When did Axonics, Inc. last raise funding?
The most recent investment in Axonics, Inc. recorded on gritt.io was in March 2019.
When was Axonics, Inc. founded?
Axonics, Inc. was founded in 2013.
What industry is Axonics, Inc. in?
Axonics, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Axonics, Inc. based?
Axonics, Inc. is headquartered in Irvine, United States.